BSEBoard Meeting1h ago · 13 Aug 2026, 04:08 pm

Outcome of Board Meeting held on 13th August, 2026

3B BlackBio Dx Ltd · 532067

✦ AI SummaryResults

3B BlackBio Dx Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, which were reviewed by the Audit Committee. The company's agrochemical business is seasonal in nature and its performance can be impacted by weather conditions and cropping patterns.

Analysis Scores

Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

3B BlackBio Dx Ltd - 532067 - Board Meeting Outcome for Outcome Of Board Meeting

Attachments (1)

📄

c48a7b33-54ee-4c32-9a9f-b44dddacc511.pdf

pdf

Download →
View document text
(Formerly – Kilpest India Limited) Ref. No.P-66/2026-27/26 August 13, 2026 The Relationship Manager, Department of Corporate Relations BSE Limited, P.J. Towers, Dalal Street Fort, MUMBAI – 400 001 Subject: Outcome of Board Meeting held on Thursday, 13th August, 2026 Pursuant to Regulations 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations),we wish to inform you that the Board of Directors of the Company at its Meeting held today i.e. 13th August, 2026, has inter-alia, considered and approved the following: 1. Financial results: Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30th June 2026. The same has also been reviewed by the Audit Committee in its meeting held today. Further, Baheti & Co., Statutory Auditors of the Company have carried out the Limited Review of the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026 and the Board has also taken on record their Limited Review Reports on the said Financial Results. A copy of the Financial Results along with Limited Review Report for the quarter ended 30th June, 2026, as required under Regulation 33 of the Listing Regulations, is attached. 2. Appointment of M/s Sanjay Kasliwal & Associates, Cost Accountants & Social Auditor, Bhopal as Cost Auditor of the Company for the FY 2026-27; The said appointment of M/s. Sanjay Kasliwal & Associates is in compliance with Section 148 of the Companies Act, 2013 and other applicable provisions, if any, read with Companies (Cost Records and Audit) Rules, 2014. The remuneration payable to M/s Sanjay Kasliwal & Associates shall be placed before the shareholders for ratification at the ensuing Annual General Meeting. Regd. Office & Factory : 7-C | Industrial Area | Govindpura | Bhopal – 462023 | (M.P.) | INDIA CIN : L24211MP1972PLC001131 Ph.: 91-755-2586536, 2586537 Email : info@kilpest.com Visit us at : www.kilpest.com (Formerly – Kilpest India Limited) The disclosure pursuant to SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed as Annexure -A The Meeting of the Board of Directors held today commenced at 3:00 P.M. and concluded at 3:50 P.M. Kindly take the same on your records. Thanking You, For 3B BlackBio Dx Limited (Formerly, Kilpest India Limited) Nikhil Kuber Dubey Whole Time Director DIN: 00538049 38 BlackBi (FormerlY AN N EXU RE-A DISCLOSURE AS PER REGULATION 30 OF LISTING REGULATIONS READ WITH SEBI MA5TER cTRCULAR No . Ho/49lt4/t4(7)2025-cFD-PoD2lrl3762/2026 dated IANUARY 30, 2026 Name M/s. Sanjay Kasliwal & Associates Reason for Appointment change viz. appointment, re- apBeintment resigffiti€ft erotj+erwise Appointed as Cost Auditor for FY 2026-27 at the Board meetlng held on 13th August, 2026, to issue Cost Audit Report as per the provisions of the ComPanies Act,20t3 Brief Profile Accountants Social (in case of has experience and he firm also appointment) Provides Records as prescribed under the Companies (Cost Records and Audit) Rules, 2014 and certification as regards maintenance of Cost Records by the Comoa nv. Disclosure of NA relationships between irectors d ( in case appointment ofao director) For38 Bla 38 BLACKBIO DX LIMITED REGD.OFFICE: 7-C, INDUSTRIAL AREA,GOVINDPURA, BHOP AL-462 023 Cl N :1242 1 1M P1972 PLC001- L3 1 (Rs. In Lakhs) S.No. PARTICULARS QUARTER ENDED YEAR ENDED 30-06-2026 3L-03-2026 30-05-202s 3L-03-2026 (U naudited) (nudited) (Unaudited) (Audited) Revenue from operations 2294.52 2463.01 2035.7r 9727.50 tl Other income 530.27 130.33 431..42 141,6.20 Total Income (l + ll) 2824.79 2s93.34 2467.L3 LLL43,7O Expenses: Cost of materials consumed 493.25 578.96 5 19.70 2345.1,6 Pu rchases of Stock-i n-Trade 0,00 0.00 0.00 0,00 Changes in inventories of finished goo€llelk-ift (2e.e4) 29.80 (s.s7) 11.69 Employee benefits expenses 182.86 225.92 148.8 1 757.93 Finance costs 0.02 0.41 0.80 4.39 Depreciation and amortization expense 23.50 29.3r 21.50 94.31, Other expenses 31.9.78 500.15 2r4.35 1294.54 Total expenses (lV) 989.47 1364.55 899.19 4s08.02 Profit/(loss) before exceptional items and tax (lll 1835.32 t228.79 1.567.94 653s.68 Exceptional items 0.00 0.00 0.00 0.00 Profit before tax (V vt) 183s.32 L228.79 ts67.94 563s.68 Tax expense: (1) Current tax 424.1,r 395.64 3 21,90 1615,49 (2) Deferred tax 0.00 88.s0 0.00 88.50 X Profit (Loss) for the period (Vll-Vlll) L4LL.2T 744.65 L246.O4 493r..69 Other Comprehensive I ncome/(loss) 0.00 0.00 0,00 0.00 Total Comprehensive Income for the period (rx+x) L4tL,2L 744.65 L246.04 493L.69 X Paid-up Equity Share capital 856.84 8s6.84 856.84 856,84 Reserve excluding Revaluation Reserves as per X balance sheet of previous year 31,044.75 26421,.76 26421.16 2642L.76 XV Earnings per equity share: (1) Basic 16.41 8,69 1,4.54 57.56 (2) Diluted 1,6.47 8.69 1,4.54 5t.56 FOR AND ON BEHALF OF THE BOARD PLACE: BHOPAL KHIL KUBER DUBEY DATE :1,3/08/2026 WHOLE TIME DIRECTOR DIN:00538049 JUNE. 2026 1. T Rh ee qu a irb eo mv ee n tr se )s Ru elt gs u a lar te io na ss , 2p 0e 1r 5R aeg i u ala mti eo nn d e3 d3 ao nf d t hh ae v es E bB eeI n( L tais kti en ng oo nb li rg ea ct oio rdn .s , b yu 1 th9 e D Bis oc alo rs du r oe f Directors at its n1.6ting held on August 13, 2026 after being reviewed by the Audit Committee' 2. The Company,s Agrochemical Business is seasonal in nature and the performance can be impacted by weather conditions and cropping pattern. 3 T Sh tae nse d af rin da sn (c Ii nal d r Aes Su ) lt as s h pa rv ee s cb re iben e dp r ue np da ere r d s eIn ct ia oc nc o 1r 3d 3an oce f Cw oi mth p t ah ne ie r se q Au cir te , m 2e 0n t3ts reo af dIn wdi ia thn A Cc oc mo pu an nti in eg s (Indian Accounting Standards) Rules, 2ol5 as amended' 4 The figures for the quarter ended March 3t, 2026 are the balancing figures between audited figures for the full financial year ended March 31, 2026 and unaudited figures for the nine months ended December 3L,202s, being the date of the end of the third quarter of the financial year/ which were subjected to limited review. 5. All the figures of financials have been rounded off to nearest lakh in rupees. 6. There is an increase in other expenses by 3o/o which is mainly because of expenditure incurred towards IVDR regulatory registration process and participation in international trade fair. previous period/year figures have been regrouped / rearranged, wherever deemed necessary' B The results of the company are available for investors at www.kilpest.com and www'bseindia.com' Limited Review: The Limited Review, as required under Regulation 33 of the SEBI (Listing obligations and Disclosure Requirements) Regulations,20l5 as ameMed, has been completed and the related Report shall be forwarded to the stock Exchanges. This Report does not have any impact on the above "Results and Notes" for the quarter ended June 30,2026 which needs to be explained. FOR AND ON BEHALF OF THE BOARD NIKHI BER DUBEY PLACE: BHOPAL DATE L3/08/2026 LE TIME DIRECTOR DIN: 00538049 BAHETI & CO, CH ART E R E D ACCO U NTA/VIS 24,M.P. NAGAR ZONE II BHOPAL 4620TT 6314r,4251535 Independent Auditor's Review Report on the Quarterly Unaudited Standalone Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2OL5, as amended Review RePort to The Board of Directors of 3B BIackBio Dx Limited (Formerly, Kilpest India Limited) 1,. We have reviewed the accompanying statement of unaudited standalone financial results of 3B BlackBio Dx Limited (Formerly, Kilpest India Limited) (the ,,Company") for the quarter ended June 30, 2026 (the "statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of'the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2O!5, as amended (the "Listing Regulations"). 2. The Company's Management is responsi [Showing first 8,000 characters — download PDF for full document]